关注
Katherine L. Cook
Katherine L. Cook
Assistant Professor, Wake Forest University School of Medicine
在 wakehealth.edu 的电子邮件经过验证
标题
引用次数
年份
“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
KL Cook, DR Soto-Pantoja
Biomarker research 5, 1-6, 2017
222017
1304 Dietary patterns associated with increased abundance of Akkermansia muciniphila potentiates anti-PD-L1 immune checkpoint blockade response in triple-negative breast cancer
K Clear, E Stirling, A Wilson, D Soto-Pantoja, K Cook
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
12022
178 Targeting ER-mitochondrial dynamics to improve responses to immune checkpoint blockade
K Cook, E Stirling, J Mackert, M Kooshki, A Wilson
J Immunother 10 (2), A1-A1595, 2022
2022
616 CD47 blockade modulates immunosuppressive checkpoint molecules and cellular metabolism to sensitize triple-negative breast cancer tumors to immune checkpoint blockade therapy
E Stirling, A Wilson, K Cook, A Thomas, P Triozzi, D Soto-Pantoja
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A646-A646, 2021
12021
79 Un “Abl” ing Anti-estrogen Therapy Resistance in Estrogen Receptor-alpha Positive Breast Cancer
KL Cook, JL Schwartz, COB Facey, L Jin, A Zwart, M Abu-Azab, A Warri, ...
European Journal of Cancer, 26, 2012
2012
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness
KL Langsten, L Shi, AS Wilson, S Lumia, B Westwood, AM Skeen, MT Xie, ...
Cancers 15 (24), 5773, 2023
2023
A Novel Model of Estrogen Receptor-Positive Breast Cancer Bone Metastasis with Antiestrogen Responsiveness
KL Langsten, L Shi, AS Wilson, B Westwood, MT Xie, VE Surratt, ...
bioRxiv, 2021.09. 16.460665, 2021
2021
A review of research on the intersection between breast cancer and cardiovascular research in the Women’s Health Initiative (WHI)
S Raychaudhuri, CM Dieli-Conwright, RK Cheng, A Barac, KW Reding, ...
Frontiers in Oncology 12, 1039246, 2023
52023
Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression
ER Stirling, YT Tsai, SM Bronson, A Wilson, B Westwood, A Thomas, ...
bioRxiv, 2023.07. 12.548766, 2023
2023
Abstract B123: A mesenchymal subset of cancers with elevated ZEB1 expression is sensitive to low doses of silver nanoparticles
CD Fahrenholtz, J Swanner, J Sears, K Cook, PA Vidi, R Singh
Molecular Cancer Therapeutics 17 (1_Supplement), B123-B123, 2018
2018
Abstract B15: Gut microbiome populations modulate neoadjuvant chemotherapy responsiveness in preclinical triple-negative breast cancer murine model
K Clear, A Wilson, A Chiba, KL Cook, A Bawaneh
Cancer Research 80 (8_Supplement), B15-B15, 2020
2020
Abstract B47: Silver nanoparticles exhibit subtype specific cytotoxic and therapeutic effects in claudin low breast cancer in vitro and in vivo
JL Swanner, I Tenvooren, BW Bernish, CD Fahrenholtz, PA Vidi, KL Cook, ...
Cancer Research 77 (2_Supplement), B47-B47, 2017
2017
Abstract LB-167: Prepubertal or lifetime genistein intake reduces risk of tamoxifen resistance in rats
X Zhang, A Warri, IM Cruz, K Cook, R Clarke, L Hilakivi-Clarke
Cancer Research 72 (8_Supplement), LB-167-LB-167, 2012
2012
Abstract P1-02-05: Endocrine-targeted therapies modify the gut microbiome affecting responsiveness in ER+ breast cancer
A Arnone, AS Wilson, A Chiba, B Kerr, DR Soto-Pantoja, A Thomas, ...
Cancer Research 83 (5_Supplement), P1-02-05-P1-02-05, 2023
2023
Abstract P1-09-03: Omega-3 polyunsaturated fatty acid supplementation shifts the gut and breast microbiome to influence inflammation
KL Cook, AS Wilson, DR Soto-Pantoja, BF Kimler, S Umar, CJ Fabian
Cancer Research 82 (4_Supplement), P1-09-03-P1-09-03, 2022
2022
Abstract P2-04-06: Targeting of the unfolded protein response signaling arms differentially regulates macrophage proliferation, plasticity, and breast cancer cell clearance
KL Cook, A Wilson, B Westwood, DR Soto-Pantoja
Cancer Research 77 (4_Supplement), P2-04-06-P2-04-06, 2017
2017
Abstract P5-08-14: Blockade of CD47/Thrombospondin-1 signaling increases glycolytic metabolism as a protective mechanism against chemotherapy-associated cardiac injury in a …
SM Bronson, JD Mackert, M Kooshki, AS Wilson, N Cruz-Diaz, PL Triozzi, ...
Cancer Research 83 (5_Supplement), P5-08-14-P5-08-14, 2023
2023
Abstract P5-14-19: Targeting the unfolded protein response components differentially sensitizes breast tumors to doxorubicin while modulating chemotherapy-induced cardiotoxicities
D Soto-Pantoja, K Clear, KL Cook
Cancer Research 80 (4_Supplement), P5-14-19-P5-14-19, 2020
2020
Abstract PO2-08-10: Effect of 6 months of bazedoxifene+ conjugated estrogens on body composition and insulin resistance
C Fabian, A Zelenchuk, K Powers, A Kreutzjans, K Pittman, B Hendry, ...
Cancer Research 84 (9_Supplement), PO2-08-10-PO2-08-10, 2024
2024
Abstract PO5-14-01: Weight loss and omega-3 polyunsaturated fatty acid intervention in overweight and obese peri-and postmenopausal women with increased breast cancer risk …
KL Cook, E Giles, A Kreutzjans, S Umar, C Befort, B Kimler, S Hursting, ...
Cancer Research 84 (9_Supplement), PO5-14-01-PO5-14-01, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20